Startseite New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).
|

New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).

Seite drucken
Seite teilen
DRFZ NewsFlash abonnieren